Drug Trial Radar · NCT06542497
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
569
Actual
Start
Aug 15, 2024
Primary completion
Apr 3, 2025
Study completion Jan 22, 2026
Sponsor
- Lead sponsor
- Opus Genetics, IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety and efficacy of POS in participants with presbyopia
Conditions
- Presbyopia
Interventions
0.75% phentolamine ophthalmic solutionDrug
Once daily dosing
PlaceboDrug
Once daily dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With ≥ 15 Letters of Improvement in Binocular DCNVA and With < 5 Letters of Loss in Binocular BCDVA From Baseline Comparing POS-treated Participants to Placebo-treated Participants at 12 Hours Post-dose at Visit 4 (Day 8)Time frame: 8 Days
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Arizona Eye Center
Chandler, Arizona
Carrot Eye Center
Mesa, Arizona
Eye Doctors of Arizona
Phoenix, Arizona
MRB Eye Care Consultants, LLC
Scottsdale, Arizona
Empire Eye & Laser Center
Bakersfield, California
Global Research Management, Inc.
Glendale, California
Gordon Schanzlin New Vision Institute
La Jolla, California
LoBue Laser and Eye Medical Center, Inc.
Murrieta, California
Eye Research Foundation
Newport Beach, California
Wolstan and Goldberg Eye Associates
Torrance, California
Segal Drug Trials, Inc.
Delray Beach, Florida
South Florida Glaucoma
Delray Beach, Florida
Levenson Eye
Jacksonville, Florida
Bowden Eye & Associates
Jacksonville, Florida
Shettle Eye Research
Largo, Florida
Sabal Eye Care/dba Omega Vision Center
Longwood, Florida
Mid Florida Eye Center
Mt. Dora, Florida
Virdi Eye Clinic
Rock Island, Illinois
Price Vision Group
Indianapolis, Indiana
Durrie Vision
Overland Park, Kansas
Kannarr Eye Care
Pittsburg, Kansas
Heart of America Eye Care, P.A.
Shawnee Mission, Kansas
The Eye Care Institute
Louisville, Kentucky
Fraser Eye Care Center
Fraser, Michigan
Moyes Eye Center
Kansas City, Missouri
Rochester Ophthalmological Group
Rochester, New York
Oculus Research , Inc.
Garner, North Carolina
Bergstrom Eye
Fargo, North Dakota
Red River Research Partners
Fargo, North Dakota
Athens Eye Care
Athens, Ohio
West Bay Eye Associates
Warwick, Rhode Island
Advancing Vision Research
Goodlettsville, Tennessee
Optometry Group
Memphis, Tennessee
Total Eye Care
Memphis, Tennessee
Whitsett Vision Group
Houston, Texas
Lake Travis Eye and Laser Center/ Revolution Research
Lakeway, Texas
Red River Research Partners
Richardson, Texas
Parkhurst NuVision
San Antonio, Texas
Eye Institute of Utah
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.